deltatrials
Completed NA INTERVENTIONAL 1-arm NCT04659564

Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled Study (DAYSPRING)

Sponsor: Koya Medical, Inc.

Conditions Breast Cancer Related Lymphedema Lymphedema Lymphedema of Upper Arm Quality of Life
Interventions User of Dayspring device
Updated 5 times since 2021 Last updated: May 28, 2021 Started: Aug 5, 2020 Primary completion: May 28, 2021 Completion: May 28, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Breast Cancer Related Lymphedema and Lymphedema and is currently completed. Koya Medical, Inc. leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Sep 2021 — Jul 2024 [monthly]

    Completed NA

    Status: Recruiting → Completed

  4. Jun 2021 — Sep 2021 [monthly]

    Recruiting NA

  5. Jan 2021 — Jun 2021 [monthly]

    Recruiting NA

    First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Koya Medical, Inc.
Data source: Koya Medical, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations